Glaxo Executives Cited in Case Now Lead Sanofi, Actelion – Businessweek


GPB

Glaxo Executives Cited in Case Now Lead Sanofi, Actelion
Businessweek
Two senior executives at GlaxoSmithKline Plc (GSK) singled out by the U.S. Justice Department for pushing the Advair asthma drug for unapproved uses have moved on to some of Europe's top pharmaceutical companies.
Glaxo Settlement Pulls Back Curtain On Drug MarketingNPR (blog)

all 36 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.